Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Herpes simplex Infection

  Free Subscription


Articles published in Vaccine

Retrieve available abstracts of 10 articles:
HTML format
Text format



Single Articles


    April 2018
  1. STANFIELD BA, Rider PJF, Caskey J, Del Piero F, et al
    Intramuscular vaccination of guinea pigs with the live-attenuated human herpes simplex vaccine VC2 stimulates a transcriptional profile of vaginal Th17 and regulatory Tr1 responses.
    Vaccine. 2018 Apr 11. pii: S0264-410X(18)30444.
    PubMed     Text format     Abstract available


    December 2017
  2. GOTTLIEB SL, Giersing BK, Hickling J, Jones R, et al
    Meeting report: Initial World Health Organization consultation on herpes simplex virus (HSV) vaccine preferred product characteristics, March 2017.
    Vaccine. 2017 Dec 7. pii: S0264-410X(17)31492.
    PubMed     Text format     Abstract available


    June 2017
  3. GOTTLIEB SL, Giersing B, Boily MC, Chesson H, et al
    Modelling efforts needed to advance herpes simplex virus (HSV) vaccine development: Key findings from the World Health Organization Consultation on HSV Vaccine Impact Modelling.
    Vaccine. 2017 Jun 21. pii: S0264-410X(17)30408.
    PubMed     Text format     Abstract available


  4. ACHDOUT H, Lustig S, Israely T, Erez N, et al
    Induction, treatment and prevention of eczema vaccinatum in atopic dermatitis mouse models.
    Vaccine. 2017 Jun 20. pii: S0264-410X(17)30791.
    PubMed     Text format     Abstract available


    September 2016
  5. FLECHTNER JB, Long D, Larson S, Clemens V, et al
    Immune responses elicited by the GEN-003 candidate HSV-2 therapeutic vaccine in a randomized controlled dose-ranging phase 1/2a trial.
    Vaccine. 2016 Sep 15. pii: S0264-410X(16)30795.
    PubMed     Text format     Abstract available


    July 2016
  6. YU X, Wang Y, Xia Y, Zhang L, et al
    A DNA vaccine encoding VP22 of herpes simplex virus type I (HSV-1) and OprF confers enhanced protection from Pseudomonas aeruginosa in mice.
    Vaccine. 2016 Jul 20. pii: S0264-410X(16)30590.
    PubMed     Text format     Abstract available


    June 2016
  7. BACCARI A, Cooney M, Blevins TP, Morrison LA, et al
    Development of a high-throughput beta-Gal-based neutralization assay for quantitation of herpes simplex virus-neutralizing antibodies in human samples.
    Vaccine. 2016 Jun 2. pii: S0264-410X(16)30323.
    PubMed     Text format     Abstract available


    March 2016
  8. NICOLI F, Gallerani E, Skarlis C, Sicurella M, et al
    Systemic immunodominant CD8 responses with an effector-like phenotype are induced by intravaginal immunization with attenuated HSV vectors expressing HIV Tat and mediate protection against HSV infection.
    Vaccine. 2016 Mar 18. pii: S0264-410X(16)00333.
    PubMed     Text format     Abstract available


  9. JOHNSTON C, Gottlieb SL, Wald A
    Status of vaccine research and development of vaccines for herpes simplex virus prepared for WHO PD-VAC.
    Vaccine. 2016 Mar 10. pii: S0264-410X(16)00297.
    PubMed     Text format     Abstract available


    November 2015
  10. ODEGARD JM, Flynn PA, Campbell DJ, Robbins SH, et al
    A novel HSV-2 subunit vaccine induces GLA-dependent CD4 and CD8 T cell responses and protective immunity in mice and guinea pigs.
    Vaccine. 2015 Nov 10. pii: S0264-410X(15)01600.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Herpes simplex Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: